These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28207087)

  • 1. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation.
    Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
    Int J Biol Markers; 2004; 19(3):221-228. PubMed ID: 28207087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.
    Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
    Int J Biol Markers; 2004; 19(3):221-8. PubMed ID: 15503824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
    Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
    J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
    Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
    ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal ranges of angiogenesis regulatory proteins in human platelets.
    Peterson JE; Zurakowski D; Italiano JE; Michel LV; Fox L; Klement GL; Folkman J
    Am J Hematol; 2010 Jul; 85(7):487-93. PubMed ID: 20575035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
    Brostjan C; Gebhardt K; Gruenberger B; Steinrueck V; Zommer H; Freudenthaler H; Roka S; Gruenberger T
    Clin Cancer Res; 2008 Apr; 14(7):2065-74. PubMed ID: 18381946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Growth: A Putative Role for Platelets?
    Verheul HM; Pinedo HM
    Oncologist; 1998; 3(2):II. PubMed ID: 10388096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet: transporter of vascular endothelial growth factor.
    Verheul HM; Hoekman K; Luykx-de Bakker S; Eekman CA; Folman CC; Broxterman HJ; Pinedo HM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2187-90. PubMed ID: 9815613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo Platelet Activation and Anomalous Thrombospondin Levels in Severe Falciparum Malaria.
    Supanaranond W; Davis TM; Dawes J; Silamut K; Vilaiwanna N; White NJ
    Platelets; 1992; 3(4):195-200. PubMed ID: 21043878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy.
    Holmes CE; Jasielec J; Levis JE; Skelly J; Muss HB
    Clin Transl Sci; 2013 Oct; 6(5):386-90. PubMed ID: 24127927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
    Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
    Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
    Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
    Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombospondin as an indicator of intravascular platelet activation in patients with vasculitis.
    McCrohan MB; Huang SW; Sleasman JW; Klein PA; Kao KJ
    Thromb Haemost; 1987 Oct; 58(3):850-2. PubMed ID: 2963403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer.
    Tokunaga T; Nakamura M; Oshika Y; Abe Y; Ozeki Y; Fukushima Y; Hatanaka H; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Tamaoki N; Ueyama Y
    Br J Cancer; 1999 Jan; 79(2):354-9. PubMed ID: 9888480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
    Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.